Liver Disease Diagnostics Market Report: Trends, Forecast and Competitive Analysis to 2030

Liver Disease Diagnostics Trends and Forecast

The future of the global liver disease diagnostics market looks promising with opportunities in the hospital and laboratoy markets. The global liver disease diagnostics market is expected to reach an estimated $50.5 billion by 2030 with a CAGR of 6.2% from 2024 to 2030. The major drivers for this market are increasing prevalence of liver diseases, rising alcohol consumption, and growing expenditure on research and development for accurate and early diagnosis of patients.

A more than 150-page report is developed to help in your business decisions.

Liver Disease Diagnostics by Segment

The study includes a forecast for the global liver disease diagnostics by diagnosis technique, end use, and region.

Liver Disease Diagnostics Market by Diagnosis Technique [Shipment Analysis by Value from 2018 to 2030]:

• Imaging
• Laboratory tests
• Endoscopy
• Biopsy
• Others

Liver Disease Diagnostics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Laboratories
• Others

Liver Disease Diagnostics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Liver Disease Diagnostics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies liver disease diagnostics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the liver disease diagnostics companies profiled in this report include-

• Abbott
• F. Hoffmann-La Roche
• Thermo Fisher Scientific
• Randox Laboratories
• Boston Scientific Corporation
• Laboratory Corporation Of America Holdings
• Fujifilm Corporation
• Horiba Medical
• Siemens Healthcare

Liver Disease Diagnostics Market Insights

Lucintel forecasts that imaging will remain the largest segment over the forecast period due to the growing number of initiatives taken by key players in the market for liver disease diagnostics so as to develop advanced imaging techniques.

Within this market, hospitals will remain the largest segment due to growing admission of patient, availability of advanced diagnostic products, and presence of well-trained nursing staff.

APAC is expected to witness highest growth over the forecast period due to increasing healthcare expenditure, growing geriatric population, and rising awarness towards regular checkups in the region.

Features of the Global Liver Disease Diagnostics Market

Market Size Estimates: Liver disease diagnostics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Liver disease diagnostics market size by diagnosis technique, end use, and region. in terms of value ($B).

Regional Analysis: Liver disease diagnostics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different diagnosis techniques, end uses, and region.s for the liver disease diagnostics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the liver disease diagnostics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the liver disease diagnostics market size?

Answer: The global liver disease diagnostics market is expected to reach an estimated $50.5 billion by 2030.

Q.2. What is the growth forecast for liver disease diagnostics market?

Answer: The global liver disease diagnostics market is expected to grow with a CAGR of 6.2% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the liver disease diagnostics market?

Answer: The major drivers for this market are increasing prevalence of liver diseases, rising alcohol consumption, and growing expenditure on research and development for accurate and early diagnosis of patients.

Q.4. What are the major segments for liver disease diagnostics market?

Answer: The future of the liver disease diagnostics market looks promising with opportunities in the hospitals and laboratories markets.

Q.5. Who are the key liver disease diagnostics market companies?

Answer: Some of the key liver disease diagnostics companies are as follows:

• Abbott
• F. Hoffmann-La Roche
• Thermo Fisher Scientific
• Randox Laboratories
• Boston Scientific Corporation
• Laboratory Corporation of America Holdings
• Fujifilm Corporation
• Horiba Medical
• Siemens Healthcare

Q.6. Which liver disease diagnostics market segment will be the largest in future?

Answer: Lucintel forecasts that imaging will remain the largest segment over the forecast period due to the growing number of initiatives taken by key players in the market for liver disease diagnostics so as to develop advanced imaging techniques.

Q.7. In liver disease diagnostics market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to increasing healthcare expenditure, growing geriatric population, and rising awarness towards regular checkups in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the liver disease diagnostics market by diagnosis technique (imaging, laboratory tests, endoscopy, biopsy, and others), end use (hospitals, laboratories, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?